Prelude Therapeutics Incorporated
PRLD
$4.66
$0.020.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.21M | 54.96M | 73.22M | 99.07M | 133.61M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.48M | 3.37M | 3.66M | 3.33M | 2.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 105.69M | 58.33M | 76.88M | 102.40M | 135.90M |
|
|
|||||
| Total Current Assets | 105.69M | 58.33M | 76.88M | 102.40M | 135.90M |
| Net Property, Plant & Equipment | 32.28M | 33.08M | 33.89M | 34.70M | 35.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.35M | 3.35M | 4.15M | 4.15M | 4.15M |
| Total Assets | 141.32M | 94.76M | 114.92M | 141.26M | 175.52M |
|
|
|||||
| Total Accounts Payable | 3.98M | 2.53M | 4.96M | 5.83M | 7.73M |
| Total Accrued Expenses | 11.57M | 11.97M | 12.37M | 10.61M | 14.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.74M | 2.73M | 2.71M | 2.65M | 2.70M |
| Total Finance Division Other Current Liabilities | 34.70M | 963.00K | 861.00K | 696.00K | 771.00K |
| Total Other Current Liabilities | 34.70M | 963.00K | 861.00K | 696.00K | 771.00K |
| Total Current Liabilities | 52.99M | 18.19M | 20.91M | 19.79M | 25.64M |
|
|
|||||
| Total Current Liabilities | 52.99M | 18.19M | 20.91M | 19.79M | 25.64M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.05M | 15.13M | 15.21M | 15.27M | 15.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.64M | 2.90M | 2.97M | 3.03M | 3.09M |
| Total Liabilities | 72.68M | 36.22M | 39.08M | 38.08M | 44.06M |
|
|
|||||
| Common Stock & APIC | 751.69M | 725.14M | 722.72M | 718.81M | 714.99M |
| Retained Earnings | -683.06M | -666.60M | -646.88M | -615.65M | -583.56M |
| Treasury Stock & Other | 8.00K | 2.00K | -1.00K | 12.00K | 35.00K |
| Total Common Equity | 68.64M | 58.53M | 75.84M | 103.18M | 131.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 68.64M | 58.53M | 75.84M | 103.18M | 131.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 68.64M | 58.53M | 75.84M | 103.18M | 131.46M |
|
|
|||||